Cancer Research

Study Reveals Common Nutrient May Enhance Cancer-Fighting Immune Cells

Study Reveals Common Nutrient May Enhance Cancer-Fighting Immune Cells

University of Chicago research indicates zeaxanthin, a nutrient found in common vegetables, could boost immune system effectiveness against cancer while complementary therapies like oncolytic viruses advance.

September 26, 2025
Circular DNA Fragments Identified as Key Factor in Glioblastoma Lethality

Circular DNA Fragments Identified as Key Factor in Glioblastoma Lethality

International researchers have discovered that rogue circular DNA fragments operating independently from chromosomes may explain why glioblastoma remains so deadly despite medical advances, potentially opening new treatment pathways.

September 22, 2025
Izotropic Corporation Secures $375,000 in Private Placement for Breast Cancer Imaging Development

Izotropic Corporation Secures $375,000 in Private Placement for Breast Cancer Imaging Development

Izotropic Corporation has closed a $375,000 private placement to fund development of its breast cancer screening technology, supporting advancements in medical imaging accuracy.

September 19, 2025
Creative Biolabs Accelerates CAR-T Therapy Innovation with Advanced Development Platform

Creative Biolabs Accelerates CAR-T Therapy Innovation with Advanced Development Platform

Creative Biolabs is enhancing CAR-T therapy research through its comprehensive development platform, offering specialized viral vectors and ready-made plasmids that address critical challenges in scalability, cost, and technical efficiency for both blood cancers and emerging solid tumor applications.

September 19, 2025
Dietary Protein Restriction May Enhance Glioblastoma Treatment Efficacy, Study Finds

Dietary Protein Restriction May Enhance Glioblastoma Treatment Efficacy, Study Finds

University of Michigan research indicates that low-protein diets combined with serine-free protein shakes could improve chemotherapy and radiation outcomes for glioblastoma patients by making tumors more vulnerable to treatment.

September 18, 2025
NCI Ends 26-Year Funding for Pediatric Brain Cancer Research Consortium

NCI Ends 26-Year Funding for Pediatric Brain Cancer Research Consortium

The National Cancer Institute's termination of funding for a long-running pediatric brain cancer research program highlights growing reliance on private sector entities like CNS Pharmaceuticals Inc. to advance critical childhood cancer treatments.

September 5, 2025
Youth-Created Panther Sculpture Symbolizes Community Partnership for Cancer Research

Youth-Created Panther Sculpture Symbolizes Community Partnership for Cancer Research

Four young artists from Boys & Girls Clubs of Broward County created a symbolic panther sculpture that merges art, community, and philanthropy to raise funds for cancer research through the Panthers on the Prowl initiative.

September 4, 2025
Wrapped in Love and Kelly Ripa Launch Limited-Edition Socks to Support Ovarian Cancer Research

Wrapped in Love and Kelly Ripa Launch Limited-Edition Socks to Support Ovarian Cancer Research

Wrapped in Love and Kelly Ripa have partnered to create limited-edition teal socks with 100% of proceeds benefiting ovarian cancer research, honoring personal losses to the disease and raising awareness during Ovarian Cancer Awareness Month.

September 4, 2025
Propanc Biopharma Secures $4 Million in Public Offering to Advance Cancer Treatment Development

Propanc Biopharma Secures $4 Million in Public Offering to Advance Cancer Treatment Development

Propanc Biopharma has closed a $4 million public offering to fund development of its novel pancreatic proenzyme therapy targeting cancer stem cells in pancreatic, ovarian, and colorectal cancers.

August 29, 2025
Nerve Damage Identified as Unexpected Cause of Cancer Immunotherapy Resistance

Nerve Damage Identified as Unexpected Cause of Cancer Immunotherapy Resistance

A multinational research team has discovered that cancer-induced nerve damage contributes to immunotherapy resistance, potentially opening new treatment avenues for patients.

August 27, 2025
Izotropic Corporation Announces $300K Private Placement and Warrant Extension for Breast Cancer Imaging Technology

Izotropic Corporation Announces $300K Private Placement and Warrant Extension for Breast Cancer Imaging Technology

Izotropic Corporation's $300,000 private placement and warrant extension provides crucial working capital to advance its breast cancer imaging technology development.

August 26, 2025
CNS Pharmaceuticals Inc. to Showcase Innovative Cancer Treatments at Webull Financial Biotech/MedTech Webinar

CNS Pharmaceuticals Inc. to Showcase Innovative Cancer Treatments at Webull Financial Biotech/MedTech Webinar

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) will present its groundbreaking cancer treatment research at the upcoming Webull Financial Corporate Connect Webinar Series, highlighting the potential of its drug candidate TPI 287 in treating brain and central nervous system cancers.

August 16, 2025
New Genetic Discovery Enhances Cancer Immunotherapy Potential

New Genetic Discovery Enhances Cancer Immunotherapy Potential

A groundbreaking genetic discovery could significantly improve the effectiveness of cancer immunotherapy, offering new hope for patients with certain types of cancer.

August 6, 2025
Lantern Pharma's Starlight Therapeutics Receives FDA Clearance for GBM Combination Trial

Lantern Pharma's Starlight Therapeutics Receives FDA Clearance for GBM Combination Trial

Starlight Therapeutics, a subsidiary of Lantern Pharma, has been cleared by the FDA to begin a Phase Ib/2a clinical trial for a novel combination therapy targeting glioblastoma multiforme, a move that could significantly impact treatment options for this aggressive brain cancer.

August 6, 2025
Intensity Therapeutics Secures $6.6 Million to Advance Cancer Treatment Research

Intensity Therapeutics Secures $6.6 Million to Advance Cancer Treatment Research

Intensity Therapeutics raises $6.6 million through an At-the-Market offering to fund clinical trials for its innovative cancer therapy, INT230-6, marking a significant step forward in the fight against cancer.

August 4, 2025
Genetic Breakthrough Could Personalize Brain Tumor Treatment

Genetic Breakthrough Could Personalize Brain Tumor Treatment

Researchers at the University of Kentucky have discovered a genetic biomarker that could help predict which glioblastoma patients may benefit from the drug bevacizumab, offering a new avenue for personalized cancer treatment.

August 1, 2025
Nan Thai Buckhead and Chef Joey Ward Unite for Charity Dinner Benefiting CURE Childhood Cancer

Nan Thai Buckhead and Chef Joey Ward Unite for Charity Dinner Benefiting CURE Childhood Cancer

Nan Thai Buckhead and MICHELIN-recommended chef Joey Ward collaborate for a charity dinner on August 26, 2025, to support CURE Childhood Cancer, highlighting the importance of community and culinary excellence in philanthropy.

July 31, 2025
Study Reveals Autoantibodies' Role in Enhancing Cancer Immunotherapy Efficacy

Study Reveals Autoantibodies' Role in Enhancing Cancer Immunotherapy Efficacy

A recent study highlights the potential of autoantibodies in predicting the effectiveness of cancer immunotherapy, offering a new avenue for personalized treatment strategies.

July 29, 2025
Creative Biolabs to Showcase Tumoroid-on-a-Chip Technology in Upcoming Webinar

Creative Biolabs to Showcase Tumoroid-on-a-Chip Technology in Upcoming Webinar

Creative Biolabs is set to host a webinar on tumoroid-on-a-chip technology, highlighting its potential to revolutionize cancer research and drug development by offering more physiologically relevant conditions for preclinical testing.

July 29, 2025
Experimental mRNA Vaccine Shows Promise in Enhancing Cancer Immunotherapy

Experimental mRNA Vaccine Shows Promise in Enhancing Cancer Immunotherapy

Researchers have discovered that an experimental mRNA vaccine could significantly improve the effectiveness of immunotherapy in fighting tumors, marking a potential advancement towards universal cancer vaccines.

July 23, 2025
Community Foundation of Broward Awards $900,000 in Grants for Cancer Research

Community Foundation of Broward Awards $900,000 in Grants for Cancer Research

The Community Foundation of Broward has awarded two grants totaling $900,000 to support innovative cancer research and treatment accessibility in Broward County, focusing on lung cancer biomarkers and melanoma immunotherapies.

July 16, 2025
Curebound Aims to Accelerate Cancer Cures Amid NIH Funding Cuts

Curebound Aims to Accelerate Cancer Cures Amid NIH Funding Cuts

Curebound, under the leadership of COO Karen Hooper, is intensifying efforts to fund innovative cancer research, especially critical in light of recent NIH funding cuts, to accelerate cures within our lifetime.

July 15, 2025
Calidi Biotherapeutics Inc. Secures $4.6 Million Through Warrant Exercise Agreement

Calidi Biotherapeutics Inc. Secures $4.6 Million Through Warrant Exercise Agreement

Calidi Biotherapeutics Inc. has raised $4.6 million by exercising outstanding warrants, funding its innovative cancer treatment research and development efforts.

July 10, 2025
Calidi Biotherapeutics' Genetic Medicine Platform Highlighted for Potential Cancer Breakthrough

Calidi Biotherapeutics' Genetic Medicine Platform Highlighted for Potential Cancer Breakthrough

Calidi Biotherapeutics Inc. (NYSE American: CLDI) has been featured in an editorial for its precision genetic medicine platform, which could revolutionize cancer treatment by targeting tumors with engineered viruses.

July 8, 2025
UC Davis Study Uncovers Genetic Mutation Affecting Immunotherapy Response in Solid Tumors

UC Davis Study Uncovers Genetic Mutation Affecting Immunotherapy Response in Solid Tumors

A study by UC Davis scientists reveals a genetic mutation that may explain why solid tumors are unresponsive to immunotherapy, potentially leading to more effective cancer treatments.

July 3, 2025
Tonix Pharmaceuticals' TNX-1700 Shows Promise in Enhancing Immunotherapy for Gastric Cancer

Tonix Pharmaceuticals' TNX-1700 Shows Promise in Enhancing Immunotherapy for Gastric Cancer

Tonix Pharmaceuticals' preclinical data reveals TNX-1700's potential to improve immunotherapy outcomes in gastric cancer by targeting immunosuppressive neutrophils.

July 3, 2025
Fermented Wheat Germ Could Enhance Immunotherapy Outcomes for Cancer Patients

Fermented Wheat Germ Could Enhance Immunotherapy Outcomes for Cancer Patients

A clinical trial at UC Davis is exploring the potential of fermented wheat germ to improve immunotherapy results for cancer patients, offering hope for better survival rates and quality of life.

June 24, 2025
Research Reveals Why Most Smokers Avoid Lung Cancer Despite Tobacco Use

Research Reveals Why Most Smokers Avoid Lung Cancer Despite Tobacco Use

A new study explains the biological mechanisms that protect most smokers from developing lung cancer, offering insights into prevention and treatment strategies.

June 23, 2025
New Study Highlights Challenges and Systemic Barriers for Liver Cancer Patients

New Study Highlights Challenges and Systemic Barriers for Liver Cancer Patients

A recent study reveals the significant hurdles faced by hepatocellular carcinoma patients, including delayed diagnoses and social stigma, calling for systemic healthcare reforms.

June 12, 2025
Rising Breast Cancer Cases Among Younger Women Highlight Need for Advanced Treatments

Rising Breast Cancer Cases Among Younger Women Highlight Need for Advanced Treatments

Recent announcements by young celebrities about their breast cancer diagnoses underscore a worrying trend of increasing prevalence among women under 50, prompting calls for more effective treatments and research into the causes.

June 10, 2025
PreviousPage 2 of 3Next